Bracco and ACIST Medical Systems Announce FDA Clearance of ACIST Pro Diagnostic System

ACIST Medical Systems, a Bracco company, has received FDA clearance for its ACIST Pro Diagnostic System, a next-generation variable-rate contrast management solution designed for interventional cardiology. The system aims to enhance precision, safety, and efficiency in image-guided cardiovascular procedures, building on the previous ACIST CVi technology. The ACIST Pro System will be launched in the U.S. after its introduction in Japan and in select European markets earlier this year.